← European Medicine Shortage Tracker · all medicines

Ifosfamide shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Ifosfamide currently has availability issues reported in 7 European registers: Austria, Germany, EU-wide, France, Ireland, Italy, Sweden.

Shortage  ATC L01AA06 · also listed as: IFOSFAMID · ifosfamide · data refreshed 8 September 2026

Key facts

As of 8 September 2026, 7 of the 9 tracked registers list current availability issues for Ifosfamide, covering 13 affected product presentations. The longest-running open report was filed in Italy on 2025-12-16 and has now been open for about 9 months. Where agencies state a cause, manufacturing problems lead with 8 of the 9 stated-cause reports, followed by active-ingredient (API) supply issues with 1. The furthest expected-resolution date currently on file is 2027-12-31; the earliest is 2026-12-31. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 4 of the open reports were filed within the last 90 days. Registers in Germany, Ireland, Italy, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Ifosfamide is coded L01AA06 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.

Shortage Listed in the EMA shortages catalogue — EU-level issue. EMA record ↗
WhereStatus & productsSinceExpected end Reason / alternativesSource
🇪🇺 EU-wide (EMA)Shortage
Ifosfamide
2026-02-12Cancerregister ↗
🇦🇹 AustriaLimited availability
Holoxan 1 g - Trockensubstanz zur Injektionsbereitung
+ 1 more products
Holoxan 2 g - Trockensubstanz zur Injektionsbereitung
2026-01-26register ↗
🇩🇪 GermanyShortage
Holoxan
+ 4 more products
IFO-cell 2g Konzentrat zur Herstellung einer Infusionslösung
IFO-cell 5 g Konzentrat zur Herstellung einer Infusionslösung
IFO-cell N 1000
IFO-cell N 2000
2026-01-212027-12-31Probleme in der Herstellung
Alternatives: N/A
register ↗
🇫🇷 FranceLimited availability
Holoxan 1000 mg, poudre pour solution injectable et 2000 mg, poudre pour usage parentéral
Hématologie, Oncologie/Radiothérapieregister ↗
🇮🇪 IrelandShortage
Mitoxana 1 g Powder for Sterile Concentrate
+ 1 more products
Mitoxana 2 g Powder for Sterile Concentrate
2026-02-252026-08-17Manufacturing delay (Multiple countries)
Alternatives: No authorised alternative listed.
register ↗
🇮🇹 ItalyShortage
HOLOXAN
2025-12-162027-03-31Elevata richiesta/problemi produttivi: distribuzione contingentata
Alternatives: AIFA: import of a foreign equivalent can be authorised.
register ↗
🇸🇪 SwedenShortage
Holoxan Pulver till injektions-/infusionsvätska, lösning
2026-01-312026-12-31
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2025-12: 12026-01: 42026-02: 22026-03: 02026-04: 12026-05: 02026-06: 02026-07: 02026-08: 42025-122026-08

Full report history (13 register entries)

Every individual register entry for Ifosfamide in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇩🇪 DEIFO-cell 5 g Konzentrat zur Herstellung einer InfusionslösungShortage2026-08-172027-12-31Probleme in der Herstellung
🇩🇪 DEIFO-cell N 1000Shortage2026-08-172027-12-31Probleme in der Herstellung
🇩🇪 DEIFO-cell N 2000Shortage2026-08-172027-12-31Probleme in der Herstellung
🇩🇪 DEIFO-cell 2g Konzentrat zur Herstellung einer InfusionslösungShortage2026-08-032027-12-31Probleme in der Herstellung
🇮🇪 IEMitoxana 2 g Powder for Sterile ConcentrateShortage2026-04-172026-08-17Manufacturing delay (Global)
🇮🇪 IEMitoxana 1 g Powder for Sterile ConcentrateShortage2026-02-252026-07-24Manufacturing delay (Multiple countries)
🇪🇺 EUIfosfamideShortage2026-02-12Cancer
🇸🇪 SEHoloxan Pulver till injektions-/infusionsvätska, lösningShortage2026-01-312026-12-31
🇦🇹 ATHoloxan 1 g - Trockensubstanz zur InjektionsbereitungLimited availability2026-01-26
🇦🇹 ATHoloxan 2 g - Trockensubstanz zur InjektionsbereitungLimited availability2026-01-26
🇩🇪 DEHoloxanShortage2026-01-212026-12-31Probleme in der Herstellung
🇮🇹 ITHOLOXANShortage2025-12-162027-03-31Elevata richiesta/problemi produttivi: distribuzione conting
🇫🇷 FRHoloxan 1000 mg, poudre pour solution injectable et 2000 mg, poudre poLimited availabilityHématologie, Oncologie/Radiothérapie

Frequently asked

Is Ifosfamide currently in shortage in Europe?

Yes. As of 8 September 2026, availability issues are reported in: Austria, Germany, EU-wide (EMA), France, Ireland, Italy, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Ifosfamide shortage expected to end?

Agency prognoses on file range from 2026-12-31 to 2027-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Ifosfamide?

9 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Ifosfamide availability data come from?

Directly from the official medicines-agency registers that list Ifosfamide: BASG (Austria), BfArM (Germany), EMA shortages catalogue (EU), ANSM (France), HPRA (Ireland), AIFA (Italy), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ifosfamide — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ifosfamide/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ifosfamide availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ifosfamide/">Ifosfamide shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Ifosfamide: availability status across 7 European registers — European Medicine Shortage Tracker (MobiDoctor), 8 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.